Skip to content

Author

Jin-Can Luo

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Nomilin Ameliorates Insulin Resistance via Modulating the Glucose Metabolism and PI3K/Akt/GLUT4 signaling pathway in Type 2 Diabetes

Type 2 diabetes (T2D) became the most prevalent metabolic diseases worldwide characterized by insulin resistance (IR). Nomilin is a bioactive triterpene compound primarily found in citrus fruits and its anti-diabetes effect has been preliminary studied. This study combined network pharmacology, bioinformatics analy...

Jin-Can Luo, Jin-Hai Luo, Bin-Cheng Han et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.